Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D De Carvalho

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Methods in Enzymology|March 18, 2020
Using epigenetic data to estimate immune composition in admixed samplesAnkur Chakravarthy, Daniel D De Carvalho
The FEBS Journal|February 5, 2021
Clinical advances in targeting epigenetics for cancer therapyShengrui Feng, Daniel D De Carvalho
STAR Protocols|June 7, 2021
Measuring the effect of drug treatments on primary human CD8+ T cell activation and cytolytic potentialHelen Loo Yau, Daniel D De Carvalho
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
DNA Methylation Profiling of Premalignant Lesions as a Path to Ovarian Cancer Early DetectionCharles A Ishak, Daniel D De Carvalho
Pharmacology & Therapeutics|October 19, 2019
The role of DNA-demethylating agents in cancer therapyParinaz Mehdipour, Tracy Murphy, Daniel D De Carvalho
Oncoscience|November 17, 2017
Drug-induced activation of "junk" DNA - A path to combat cancer therapy resistance?Marie Classon, Kelly LaMarco, Daniel D De Carvalho
Nature Cancer|February 5, 2022
The next generation of DNMT inhibitorsParinaz Mehdipour, Raymond Chen, Daniel D De Carvalho
Molecular Oncology|November 26, 2024
Viral mimicry evasion: a new role for oncogenic KRAS mutationsRaymond Chen, Aobo He, Daniel D De Carvalho
Methods in Enzymology|November 16, 2019
Methods to detect endogenous dsRNA induction and recognitionIlias Ettayebi, Helen Loo Yau, Daniel D De Carvalho
Trends in Cancer|August 2, 2018
Deregulation of Retroelements as an Emerging Therapeutic Opportunity in CancerCharles A Ishak, Marie Classon, Daniel D De Carvalho
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Methods in Enzymology|March 18, 2020
Using epigenetic data to estimate immune composition in admixed samplesAnkur Chakravarthy, Daniel D De Carvalho
The FEBS Journal|February 5, 2021
Clinical advances in targeting epigenetics for cancer therapyShengrui Feng, Daniel D De Carvalho
STAR Protocols|June 7, 2021
Measuring the effect of drug treatments on primary human CD8+ T cell activation and cytolytic potentialHelen Loo Yau, Daniel D De Carvalho
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
DNA Methylation Profiling of Premalignant Lesions as a Path to Ovarian Cancer Early DetectionCharles A Ishak, Daniel D De Carvalho
Pharmacology & Therapeutics|October 19, 2019
The role of DNA-demethylating agents in cancer therapyParinaz Mehdipour, Tracy Murphy, Daniel D De Carvalho
Oncoscience|November 17, 2017
Drug-induced activation of "junk" DNA - A path to combat cancer therapy resistance?Marie Classon, Kelly LaMarco, Daniel D De Carvalho
Nature Cancer|February 5, 2022
The next generation of DNMT inhibitorsParinaz Mehdipour, Raymond Chen, Daniel D De Carvalho
Molecular Oncology|November 26, 2024
Viral mimicry evasion: a new role for oncogenic KRAS mutationsRaymond Chen, Aobo He, Daniel D De Carvalho
Methods in Enzymology|November 16, 2019
Methods to detect endogenous dsRNA induction and recognitionIlias Ettayebi, Helen Loo Yau, Daniel D De Carvalho
Trends in Cancer|August 2, 2018
Deregulation of Retroelements as an Emerging Therapeutic Opportunity in CancerCharles A Ishak, Marie Classon, Daniel D De Carvalho
Pageof 10